910 related articles for article (PubMed ID: 33792762)
1. Toxicology and pharmacology of synthetic organoselenium compounds: an update.
Nogueira CW; Barbosa NV; Rocha JBT
Arch Toxicol; 2021 Apr; 95(4):1179-1226. PubMed ID: 33792762
[TBL] [Abstract][Full Text] [Related]
2. Organoselenium compounds as mimics of selenoproteins and thiol modifier agents.
Barbosa NV; Nogueira CW; Nogara PA; de Bem AF; Aschner M; Rocha JBT
Metallomics; 2017 Dec; 9(12):1703-1734. PubMed ID: 29168872
[TBL] [Abstract][Full Text] [Related]
3. Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds.
Nogueira CW; Rocha JB
Arch Toxicol; 2011 Nov; 85(11):1313-59. PubMed ID: 21720966
[TBL] [Abstract][Full Text] [Related]
4. Glutathione peroxidase (GPx)-like antioxidant activity of the organoselenium drug ebselen: unexpected complications with thiol exchange reactions.
Sarma BK; Mugesh G
J Am Chem Soc; 2005 Aug; 127(32):11477-85. PubMed ID: 16089478
[TBL] [Abstract][Full Text] [Related]
5. Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation.
Santi C; Scimmi C; Sancineto L
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299505
[TBL] [Abstract][Full Text] [Related]
6. Selenium and selenoproteins in viral infection with potential relevance to COVID-19.
Zhang J; Saad R; Taylor EW; Rayman MP
Redox Biol; 2020 Oct; 37():101715. PubMed ID: 32992282
[TBL] [Abstract][Full Text] [Related]
7. In vitro glutathione peroxidase mimicry of ebselen is linked to its oxidation of critical thiols on key cerebral suphydryl proteins - A novel component of its GPx-mimic antioxidant mechanism emerging from its thiol-modulated toxicology and pharmacology.
Kade IJ; Balogun BD; Rocha JB
Chem Biol Interact; 2013 Oct; 206(1):27-36. PubMed ID: 23933410
[TBL] [Abstract][Full Text] [Related]
8. Renal and hepatic ALA-D activity and selected oxidative stress parameters of rats exposed to inorganic mercury and organoselenium compounds.
Perottoni J; Rodrigues OE; Paixão MW; Zeni G; Lobato LP; Braga AL; Rocha JB; Emanuelli T
Food Chem Toxicol; 2004 Jan; 42(1):17-28. PubMed ID: 14630126
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Antioxidant Properties of Organoselenium Compounds.
Mamgain R; Kostic M; Singh FV
Curr Med Chem; 2023; 30(21):2421-2448. PubMed ID: 35927897
[TBL] [Abstract][Full Text] [Related]
10. The effects of thiol compounds and ebselen on nitric oxide activity in rat aortic vascular responses.
Kim HR; Kim JW; Park JY; Je HD; Lee SY; Huh IH; Sohn UD
J Auton Pharmacol; 2001 Feb; 21(1):23-8. PubMed ID: 11422575
[TBL] [Abstract][Full Text] [Related]
11. The early research and development of ebselen.
Parnham MJ; Sies H
Biochem Pharmacol; 2013 Nov; 86(9):1248-53. PubMed ID: 24012716
[TBL] [Abstract][Full Text] [Related]
12. Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways.
Azad GK; Tomar RS
Mol Biol Rep; 2014 Aug; 41(8):4865-79. PubMed ID: 24867080
[TBL] [Abstract][Full Text] [Related]
13. Induction of cellular necrosis by the glutathione peroxidase mimetic ebselen.
Guérin PJ; Gauthier ER
J Cell Biochem; 2003 May; 89(1):203-11. PubMed ID: 12682920
[TBL] [Abstract][Full Text] [Related]
14. Unusually short chalcogen bonds involving organoselenium: insights into the Se-N bond cleavage mechanism of the antioxidant ebselen and analogues.
Thomas SP; Satheeshkumar K; Mugesh G; Guru Row TN
Chemistry; 2015 Apr; 21(18):6793-800. PubMed ID: 25766307
[TBL] [Abstract][Full Text] [Related]
15. Neuropharmacology of Organoselenium Compounds in Mental Disorders and Degenerative Diseases.
Birmann PT; Casaril AM; Abenante L; Penteado F; Brüning CA; Savegnago L; Lenardão EJ
Curr Med Chem; 2023; 30(21):2357-2395. PubMed ID: 35708081
[TBL] [Abstract][Full Text] [Related]
16. Identification of methionine aminopeptidase 2 as a molecular target of the organoselenium drug ebselen and its derivatives/analogues: Synthesis, inhibitory activity and molecular modeling study.
Węglarz-Tomczak E; Burda-Grabowska M; Giurg M; Mucha A
Bioorg Med Chem Lett; 2016 Nov; 26(21):5254-5259. PubMed ID: 27692546
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial Activity of Ebselen.
Maślanka M; Mucha A
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675123
[TBL] [Abstract][Full Text] [Related]
18. Molecular actions of ebselen--an antiinflammatory antioxidant.
Schewe T
Gen Pharmacol; 1995 Oct; 26(6):1153-69. PubMed ID: 7590103
[TBL] [Abstract][Full Text] [Related]
19. Nano-based formulations as an approach for providing a novel identity for organoselenium compounds.
Sari MHM; Ferreira LM; Prado VC; Nogueira CW; Cruz L
Eur J Pharm Biopharm; 2022 Sep; 178():69-81. PubMed ID: 35932964
[TBL] [Abstract][Full Text] [Related]
20. Ebselen and diphenyl diselenide against fungal pathogens: A systematic review.
Benelli JL; Poester VR; Munhoz LS; Melo AM; Trápaga MR; Stevens DA; Xavier MO
Med Mycol; 2021 May; 59(5):409-421. PubMed ID: 33421963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]